6[7]Anderson D,Shelley S,Kellett N,et al.The effect of nateglinide taken with food on gastric emptying rates in healthy subjects[J].Clin Ther,2003,25(6):1722.
7[8]McLeod JF.Clinical pharmacokinetics of nateglinide:a rapidly-absorbed,short-acting insulinotropic agent[J].Clin Pharmacokinet,2004,43(2):97.
8[9]Gregorio F,Ambrosi F,Boemi M,et al.Effects of S 21403 on hormone secretion from isolated rat pancreas at different glucose concentrations[J].Eur J Pharmacol,2002,456(13):141.
4[1]Kramer W, Muller G, Girbig F, et al. Differential interaction of glimepiride and glibenclamide with the βcell sulfonylurea receptor Ⅱ.Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride. Biochim Biophys Acta, 1994, 1191(2):278
5[2]Muller G, Hartz D, Punter J, et al. Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor Ⅰ. Binding characteristics. Biochim Biophys Acta, 1994,1191(2):267
6[3]Massi-Bendetti M, Herz M, Pfeiffer C. The effects of acute exercise on metabolic control in type Ⅱ diabetic patients treated with glimepiride and glibenclamide. Horm Metab Res, 1996,28(9) :451
7[4]Geisen K, Vegh A, Krause E, et al. Cardiovascular effects of conventional sulfony1ureas and glimepiride. Horm Metab Res,1996, 28(9):496
8[5]Bijlstra PJ, Lutterman JA, Rusel FG, et al. Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans. Diabetologia, 1996, 39 (9):1083
9[6]Muller G, Satoh Y, Geisen K. Extra-pancreatic effects of sulfonylurea-a comparison between glimepiride and conventional sulfonylurea. Diabetes Res Clin Pract, 1995(Suppl 28):115
10Malaiss WJ. Stimulation of insulin release by non-sulfonylurea hypoglycemic agents. The meglitinide family [ J ]. Horm Metab Res, 1995,27( 1 ):263-266.
